Predictive Oncology (NASDAQ:POAI) Changing the landscape of oncology drug discovery&enabling development of more effective therapies in the treatment of cancer.predictive-oncology.com Pittsburgh, PAJoined April 2018
@flaatty Peter, please let us know what happened in calls past and we will address it with the company that supports our shareholder calls. We want to make sure this is not an issue moving forward.
We wanted to extend our apologies for the technical difficulties with the shareholder call yesterday.If you weren’t able to connect for questions, we look forward to further discussion during a Townhall we're planning after Thanksgiving & will keep you posted w/details. $POAI 1/2
@IncendioLSX Absolutely! This is a fantastic appointment because Raymond has the vision and experience to propel our business growth forward. He brings a fresh perspective and understands how our products fit into the industry.
Predictive Oncology appoints Raymond F. Vennare as CEO. An accomplished senior executive in life sciences, Mr. Vennare brings more than three decades of experience building and launching innovative biotechnology companies.
Read more here: hubs.la/Q01qgNsH0. $POAI
Recently, our SVP Pamela Bush, Ph.D. sat down with @CheckRare to share insight into our Proof of Concept Study—which demonstrated that our PeDAL platform can predict a tumor’s response to a drug with 92% accuracy. Check it out here: checkrare.com/using-artifici…
Pamela Bush, PhD, of Predictive Oncology, talks about the company’s technology to use artificial intelligence #AI to develop cancer medications. @PredictiveOnccheckrare.com/using-artifici…
We're gearing up for the Augmented Intelligence (AI) in Drug Discovery Xchange in San Francisco this Friday. Predictive Oncology SVP Pamela A. Bush, Ph.D., will be on hand to deliver the keynote and network with attendees. Will we see you there? hubs.la/Q01n35Tm0
Recently, we put our PeDAL platform to the test to prove its value as a tool for AI-driven drug discovery. This hands-on testing revealed exciting results. Get an advanced look at this impressive Proof of Concept report here: hubs.la/Q01n063-0
We wish our best to CEO Mel Engle as he announces his retirement, effective Oct. 31. Mel has played an instrumental role in setting up Predictive Oncology for the next stage of growth. This includes several key developments to further strengthen our offerings in drug development.
Predictive Oncology strengthens business and product offerings with the appointment of Chief Scientific Officer, Julia Kirshner, Ph.D., and consolidation and expansion of its research and development arm. $POAI investors.predictive-oncology.com/news-releases/…
We are driven by the impact we have in reducing risk & moving candidates forward confidently with 3D cell culture technology. We're producing more reliable outcomes in drug development and advancing anticancer drug candidates with our zPREDICTA line & Labcorp partnership. $POAI
Pamela Bush, PhD, of Predictive Oncology, talks about the company’s technology to use artificial intelligence #AI to develop cancer medications. @PredictiveOnccheckrare.com/using-artifici…
At the heart of POAI is a team of people who share a dedication in the fight against cancer. Some affected personally-themselves or with others. Behind the business side is a deep motivation. We are in this for the long run. This is just one story of many.
linkedin.com/posts/prmarket…
Congratulations to Predictive Oncology's own Dr. Larry DeLucas for being named to the Top 50 Over 50! While we know Dr. DeLucas is talented beyond measure, we appreciate it when our leaders are recognized by others for their many achievements. $POAI #top50over50#drugdevelopment
From partnering meetings to networking events, the Predictive Oncology team represented at BIO International in San Diego this week. Our SVP of Strategic Sales and Business Development, Dr. Pamela Bush, was even interviewed for the I am BIO podcast & a BIO video.
#BIO2022 $POAI
BIO International kicked off yesterday and our team was in full force networking and meeting with companies that can use our technologies to advance the drug discovery process. Today is Day 2 & we are ready to roll! DM us to connect if you're here. $POAI #BIO2022#pharma
218 Followers 58 FollowingOrganic due diligence: identifying emerging technologies, the institutions bringing them to market, and the impacts they may have
5K Followers 2K FollowingWe're the most accurate Black Box alert system on the market. We don't offer any financial advice. Our info is for research only! https://t.co/efsGME5bgG
530 Followers 1K FollowingWith research and communication, WAGMI. Together, we can make stock and crypto investing more fun and profitable.
Not Financial Advice. DYOR. LFG.
18K Followers 451 Followingأ.د.هاشم مساعد الطبطبائي رئيس سابق لقسم الهندسة المدنية (جامعة الكويت) لمستخدمي التويتر.. الموقع لابداء الرأي والقبول بان هناك رأي آخر مختلف عن رأيك
1K Followers 402 FollowingHarnessing the power of your tumor to personalize your therapy today and the patients of tomorrow.
A Predictive Oncology Company , @PredictiveOnc